Natural Killer Cells Therapeutics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG206186 | Category: Medical Care | Pages: 61 | Format: PDF | Published Date: September 05,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cells Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cells Therapeutics. This report contains market size and forecasts of Natural Killer Cells Therapeutics in global, including the following market information:
Global Natural Killer Cells Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Natural Killer Cells Therapeutics market was valued at US$ 263.2 million in 2022 and is projected to reach US$ 399 million by 2029, at a CAGR of 6.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Natural Killer Cells Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer Cells Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Natural Killer Cells Therapeutics Market Segment Percentages, by Type, 2022 (%)
    NK Cell Therapies
    NK Cell Directed Antibodies
Global Natural Killer Cells Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Natural Killer Cells Therapeutics Market Segment Percentages, by Application, 2022 (%)
    Research Centers & Institutes
    Hospitals
    Others
Global Natural Killer Cells Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Natural Killer Cells Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Natural Killer Cells Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Natural Killer Cells Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Affimed
    Celgene Corporation
    Fate Therapeutics
    Fortress Biotech
    Glycostem Therapeutics
    Innate Pharma
    Nantkwest
    Nkarta Therapeutics
    NKT Therapeutics
    Ziopharm Oncology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Natural Killer Cells Therapeutics, market overview.
Chapter 2: Global Natural Killer Cells Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Natural Killer Cells Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Natural Killer Cells Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Natural Killer Cells Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Natural Killer Cells Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cells Therapeutics Overall Market Size
    2.1 Global Natural Killer Cells Therapeutics Market Size: 2022 VS 2029
    2.2 Global Natural Killer Cells Therapeutics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Natural Killer Cells Therapeutics Players in Global Market
    3.2 Top Global Natural Killer Cells Therapeutics Companies Ranked by Revenue
    3.3 Global Natural Killer Cells Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Natural Killer Cells Therapeutics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Natural Killer Cells Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cells Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Natural Killer Cells Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cells Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Natural Killer Cells Therapeutics Market Size Markets, 2022 & 2029
        4.1.2 NK Cell Therapies
        4.1.3 NK Cell Directed Antibodies
    4.2 By Type - Global Natural Killer Cells Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Natural Killer Cells Therapeutics Revenue, 2018-2023
        4.2.2 By Type - Global Natural Killer Cells Therapeutics Revenue, 2024-2029
        4.2.3 By Type - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Natural Killer Cells Therapeutics Market Size, 2022 & 2029
        5.1.2 Research Centers & Institutes
        5.1.3 Hospitals
        5.1.4 Others
    5.2 By Application - Global Natural Killer Cells Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Natural Killer Cells Therapeutics Revenue, 2018-2023
        5.2.2 By Application - Global Natural Killer Cells Therapeutics Revenue, 2024-2029
        5.2.3 By Application - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Natural Killer Cells Therapeutics Market Size, 2022 & 2029
    6.2 By Region - Global Natural Killer Cells Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Natural Killer Cells Therapeutics Revenue, 2018-2023
        6.2.2 By Region - Global Natural Killer Cells Therapeutics Revenue, 2024-2029
        6.2.3 By Region - Global Natural Killer Cells Therapeutics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Natural Killer Cells Therapeutics Revenue, 2018-2029
        6.3.2 US Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.3.3 Canada Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.3.4 Mexico Natural Killer Cells Therapeutics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Natural Killer Cells Therapeutics Revenue, 2018-2029
        6.4.2 Germany Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.4.3 France Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.4.4 U.K. Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.4.5 Italy Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.4.6 Russia Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.4.7 Nordic Countries Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.4.8 Benelux Natural Killer Cells Therapeutics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Natural Killer Cells Therapeutics Revenue, 2018-2029
        6.5.2 China Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.5.3 Japan Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.5.4 South Korea Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.5.5 Southeast Asia Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.5.6 India Natural Killer Cells Therapeutics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Natural Killer Cells Therapeutics Revenue, 2018-2029
        6.6.2 Brazil Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.6.3 Argentina Natural Killer Cells Therapeutics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Natural Killer Cells Therapeutics Revenue, 2018-2029
        6.7.2 Turkey Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.7.3 Israel Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.7.4 Saudi Arabia Natural Killer Cells Therapeutics Market Size, 2018-2029
        6.7.5 UAE Natural Killer Cells Therapeutics Market Size, 2018-2029
7 Natural Killer Cells Therapeutics Companies Profiles
    7.1 Affimed
        7.1.1 Affimed Company Summary
        7.1.2 Affimed Business Overview
        7.1.3 Affimed Natural Killer Cells Therapeutics Major Product Offerings
        7.1.4 Affimed Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.1.5 Affimed Key News & Latest Developments
    7.2 Celgene Corporation
        7.2.1 Celgene Corporation Company Summary
        7.2.2 Celgene Corporation Business Overview
        7.2.3 Celgene Corporation Natural Killer Cells Therapeutics Major Product Offerings
        7.2.4 Celgene Corporation Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.2.5 Celgene Corporation Key News & Latest Developments
    7.3 Fate Therapeutics
        7.3.1 Fate Therapeutics Company Summary
        7.3.2 Fate Therapeutics Business Overview
        7.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.3.5 Fate Therapeutics Key News & Latest Developments
    7.4 Fortress Biotech
        7.4.1 Fortress Biotech Company Summary
        7.4.2 Fortress Biotech Business Overview
        7.4.3 Fortress Biotech Natural Killer Cells Therapeutics Major Product Offerings
        7.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.4.5 Fortress Biotech Key News & Latest Developments
    7.5 Glycostem Therapeutics
        7.5.1 Glycostem Therapeutics Company Summary
        7.5.2 Glycostem Therapeutics Business Overview
        7.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.5.5 Glycostem Therapeutics Key News & Latest Developments
    7.6 Innate Pharma
        7.6.1 Innate Pharma Company Summary
        7.6.2 Innate Pharma Business Overview
        7.6.3 Innate Pharma Natural Killer Cells Therapeutics Major Product Offerings
        7.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.6.5 Innate Pharma Key News & Latest Developments
    7.7 Nantkwest
        7.7.1 Nantkwest Company Summary
        7.7.2 Nantkwest Business Overview
        7.7.3 Nantkwest Natural Killer Cells Therapeutics Major Product Offerings
        7.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.7.5 Nantkwest Key News & Latest Developments
    7.8 Nkarta Therapeutics
        7.8.1 Nkarta Therapeutics Company Summary
        7.8.2 Nkarta Therapeutics Business Overview
        7.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.8.5 Nkarta Therapeutics Key News & Latest Developments
    7.9 NKT Therapeutics
        7.9.1 NKT Therapeutics Company Summary
        7.9.2 NKT Therapeutics Business Overview
        7.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Major Product Offerings
        7.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.9.5 NKT Therapeutics Key News & Latest Developments
    7.10 Ziopharm Oncology
        7.10.1 Ziopharm Oncology Company Summary
        7.10.2 Ziopharm Oncology Business Overview
        7.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Major Product Offerings
        7.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue in Global Market (2018-2023)
        7.10.5 Ziopharm Oncology Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Natural Killer Cells Therapeutics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?